Apogee Therapeutics CFO Sells 1,500 Shares
I'm PortAI, I can summarize articles.
Reporter NameHenderson JaneRelationshipChief Financial Officer, 10% OwnerTypeSellAmount$120,000SEC FilingForm 4Jane Henderson, Chief Financial Officer and 10% owner of Apogee Therapeutics, sold 1,500 shares of common stock on December 19, 2025, at a price of $80.0 per share, totaling $120,000. Following the transaction, Henderson directly owns 193,371 shares of the company. The sale was executed under a Rule 10b5-1 trading plan adopted on September 27, 2024.SEC Filing: Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Dec. 23, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments